Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Fibrosis and STAT3[original query] |
|---|
| GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. Journal of hepatology 2012 Jan 56 (1): 184-91. Nault Jean Charles, Fabre Monique, Couchy Gabrielle, Pilati Camilla, Jeannot Emmanuelle, Tran Van Nhieu Jeanne, Saint-Paul Marie-Christine, De Muret Anne, Redon Marie-José, Buffet Catherine, Salenave Sylvie, Balabaud Charles, Prevot Sophie, Labrune Philippe, Bioulac-Sage Paulette, Scoazec Jean-Yves, Chanson Philippe, Zucman-Rossi Jessi |
| Initial interrogation, confirmation and fine mapping of modifying genes: STAT3, IL1B and IFNGR1 determine cystic fibrosis disease manifestation. European journal of human genetics : EJHG 2011 Dec 19 (12): 1281-8. Labenski Heike, Hedtfeld Silke, Becker Tim, Tümmler Burkhard, Stanke Frau |
| Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nature medicine 2016 Apr . Laklai Hanane, Miroshnikova Yekaterina A, Pickup Michael W, Collisson Eric A, Kim Grace E, Barrett Alex S, Hill Ryan C, Lakins Johnathon N, Schlaepfer David D, Mouw Janna K, LeBleu Valerie S, Roy Nilotpal, Novitskiy Sergey V, Johansen Julia S, Poli Valeria, Kalluri Raghu, Iacobuzio-Donahue Christine A, Wood Laura D, Hebrok Matthias, Hansen Kirk, Moses Harold L, Weaver Valerie |
| The detection and significance of cystic fibrosis transmembrane conductance regulator gene promoter mutations in Chinese patients with congenital bilateral absence of the vas deferens. Gene 2018 Jun . Bai Song, Du Qiang, Liu Xiaoliang, Tong Yuxin, Wu B |
| The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. Journal of medicinal food 2019 7 22 (7): 729-740. Kaliora Andriana C, Gioxari Aristea, Kalafati Ioanna Panagiota, Diolintzi Anastasia, Kokkinos Alexandros, Dedoussis George |
| Analysis of CF patient survival confirms STAT3 as a CF-modifying gene with changing impact over time. Human molecular genetics 2022 9 32 (4): 543-550. Dunsche Inga, Raddatz Ellen L, Ismer Haide, Hedtfeld Silke, Tamm Stephanie, Moser Saskia, Kontsendorn Julia, Tümmler Burkhard, Janciauskiene Sabina, Dittrich Anna-Maria, Stanke Frau |
| Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. Cells 2023 8 12 (15): . Aurora Gómez-Vecino, Roberto Corchado-Cobos, Adrián Blanco-Gómez, Natalia García-Sancha, Sonia Castillo-Lluva, Ana Martín-García, Marina Mendiburu-Eliçabe, Carlos Prieto, Sara Ruiz-Pinto, Guillermo Pita, Alejandro Velasco-Ruiz, Carmen Patino-Alonso, Purificación Galindo-Villardón, María Linarejos Vera-Pedrosa, José Jalife, Jian-Hua Mao, Guillermo Macías de Plasencia, Andrés Castellanos-Martín, María Del Mar Sáez-Freire, Susana Fraile-Martín, Telmo Rodrigues-Teixeira, Carmen García-Macías, Julie Milena Galvis-Jiménez, Asunción García-Sánchez, María Isidoro-García, Manuel Fuentes, María Begoña García-Cenador, Francisco Javier García-Criado, Juan Luis García-Hernández, María Ángeles Hernández-García, Juan Jesús Cruz-Hernández, César Augusto Rodríguez-Sánchez, Alejandro Martín García-Sancho, Estefanía Pérez-López, Antonio Pérez-Martínez, Federico Gutiérrez-Larraya, Antonio J Cartón, José Ángel García-Sáenz, Ana Patiño-García, Miguel Martín, Teresa Alonso-Gordoa, Christof Vulsteke, Lieselot Croes, Sigrid Hatse, Thomas Van Brussel, Diether Lambrechts, Hans Wildiers, Hang Chang, Marina Holgado-Madruga, Anna González-Neira, Pedro L Sánchez, Jesús Pérez Losa |
| [Molecular Mechanism-based Prediction of Interstitial Lung Disease Development Causedby Molecular Targeted Drugs: Association between Signal Transducer and Activator of Transcription 3 and Mammalian Target of Rapamycin inhibitor-induced Interstitial Lung Disease]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2023 11 143 (11): 911-916. Kazuhiro Yamamo |
- Page last reviewed:Feb 1, 2024
- Content source: